Rituximab ELISA (mAb-based)
Enzyme immunoassay for the specific and quantitative determination of free Rituximab (Rituxan®, Mabthera®) in serum and plasma.
The solid phase (MTP) is coated by a highly specific monoclonal antibody directed against Rituximab. Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.
Reference: IG-AB106
Barcode: 8682754930189
Legal Status: CE-Mark
Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Related Documents
Instructions for Use IG-AB106 736.63 KB
Material Safety Data Sheet (MSDS) IG-AB106 303.94 KB
Quality Control Certificates
Quality Control Certificate Lot: AB106-107 306.65 KB
Quality Control Certificate Lot: AB106-106 149.11 KB
Quality Control Certificate Lot: AB106-105 160.00 KB
Quality Control Certificate Lot: AB106-104 160.58 KB
Quality Control Certificate Lot: AB106-103 160.45 KB
Quality Control Certificate Lot: AB106-102 160.39 KB
Rituxan® and Mabthera® are trademarks of Biogen Idec/Genentech Inc.
The Kit at a glance:
| Required Volume (µL) | 10 |
| Incubation Time (min) | 100 |
| Sample | Serum or Plasma |
| Package Size | 96 Tests |
| Standard Range (ng/mL, 10x) | 0-2000 |
| Detection Limit (ng/mL) | 5 |
| Spike Recovery (%) | >95 |
| Shelf Life (years) | 2 |
Standard Curve:
